AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Transgene AGM Information 2021

May 26, 2021

1715_iss_2021-05-26_0fd545dc-a558-4270-97c5-03db54d49dc3.pdf

AGM Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

PRESS RELEASE

Combined General Meeting of May 26, 2021

Strasbourg, France, May 26, 2021, 05:45 p.m. CET – The Combined Ordinary and Extraordinary General Meeting of Transgene's shareholders was held today (May 26, 2021) at 10:00 a.m. at the Company's headquarters (400 boulevard Gonthier d'Andernach - Parc d'Innovation - 67400 Illkirch-Graffenstaden - France) chaired by Hedi Ben Brahim, Chairman and CEO, to approve the Company's financial statements for the year ended December 31, 2020 and to vote the other resolutions submitted to their approval. As a result of restrictions placed on the movement and gatherings of persons in the context of the COVID-19 pandemic, this General Meeting was held behind closed doors without the physical presence of its shareholders. Its replay is available via Transgene's website and here.

At the Combined General Meeting, the shareholders adopted all resolutions recommended for approval by the Board of Directors.

Detailed voting results are available on Transgene's website, under the heading Investors > General Meeting.

Contacts

Transgene:

Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 [email protected]

Media: